Skip to main content
Clinical Trials/NCT05553275
NCT05553275CompletedNot Applicable

Permissive Intrapartum Glucose Control: An Equivalence Randomized Control Study (PERMIT)

The University of Texas Health Science Center, Houston2 sites in 1 country96 target enrollmentStarted: October 5, 2022Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
96
Locations
2
Primary Endpoint
first neonatal blood glucose level measured in mg/dL

Study Overview

Brief Summary

The purpose of this study is to assess whether permissive intrapartum glycemic control compared to usual care would lead to similar rate of neonatal hypoglycemia among people with diabetes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Singleton gestation
  • Presenting for intrapartum management (induction, labor, augmentation)
  • Any diagnosis of Type 1 Diabetes Mellitus(T1DM), Type 2 Diabetes Mellitus (T2DM), or Gestational Diabetes
  • English or Spanish fluency

Exclusion Criteria

  • Major fetal anomalies affecting glucose metabolism
  • Multiple Gestation
  • Incarcerated subjects
  • less than 34 weeks gestation of pregnancy
  • Planned cesarean delivery
  • Utilizing insulin pump during labor
  • Stillbirth
  • Presenting in Diabetic ketoacidosis(DKA)

Outcomes

Primary Outcomes

first neonatal blood glucose level measured in mg/dL

Time Frame: up to 2 hours of life prior to first feed

Secondary Outcomes

  • Number of neonatal deaths(within 28 days of birth)
  • Number of neonates with Apgar score of less than 7(5 minutes from birth)
  • Neonatal C-peptide levels from cord blood(at time of delivery)
  • Maximum Bilirubin level(during admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year)
  • Number of participants that undergo primary cesarean section(at time of delivery)
  • Mean neonatal glucose level in first 24 hours of life(during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year)
  • Number of intrapartum glucose measurements(During Labor(for up to 200 hours))
  • Number of gestational diabetes participants that do an oral glucose tolerance test (OGTT)(within 6- 8 weeks of delivery)
  • Lowest neonatal glucose level(first 24 hours of life)
  • Number of neonates that required shoulder dystocia(at time of delivery)
  • Number of fetal deaths(during labor defined as time patient is admitted to labor and delivery until birth time of neonate, for up to 200 hours)
  • Number of neonates that are admitted to Neonatal intensive care unit (NICU)(from birth up to 6 months from birth)
  • Overall mean maternal glucose values in mg/dl(in all of labor(for up to 200 hours))
  • Number of participants that have hyperglycemia episodes(during labor( for up to 200 hours))
  • Maximum insulin Glucose tolerance test (GTT) rate(during labor(for up to 200 hours))
  • Number of participants that have Postpartum hemorrhage(from discharge until 6 months after birth)
  • Resource utilization during labor as assessed by the number of accuchecks done(during delivery admission (labor or induction/augmentation) until delivery defined as time patient is admitted to labor and delivery until birth time of neonate, for up to 200 hours)
  • Total facility and physician costs for all the services provided to the neonates(from birth time to discharge time defined as birth time of neonate until neonate is discharged from the hospital, up to 1 year)
  • Mean maternal glucose values in mg/dl(during active labor(for up to 200 hours))
  • Number of participants that have hypoglycemia episodes(during labor(for up to 200 hours))
  • Number of participants that have Diabetic Ketoacidosis(during labor(for up to 200 hours))
  • Number pf participants that have Intra-amniotic Infection(intrapartum or within 24 hours of delivery)
  • Number pf participants that have endometriosis(Between 24 hours after delivery to 6 weeks of delivery)
  • Number pf participants that require blood product transfusion(during admission (for up to 6 weeks after neonate delivery))
  • Total facility and physician costs for all the services provided to the mothers(From maternal admission time to maternal discharge time(upto 6 months form admission date))
  • Total nurse time cost for monitoring the patients during labor(From admission time to delivery time defined as time patient is admitted to labor and delivery until birth time of neonate, for up to 200 hours)
  • Number of neonates that had birth injury(from birth and during admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year)
  • Number of neonates that need oral glucose supplementation(during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year)
  • Number of neonates that need IV glucose(during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year)
  • Number of participants that utilize insulin drip(during labor(for up to 200 hours))
  • Number pf participants that have wound complications(within 6 weeks of delivery)
  • Resource utilization during labor as assessed by the number of nurses utilized(during delivery admission (labor or induction/augmentation) until delivery defined as time patient is admitted to labor and delivery until birth time of neonate, for up to 200 hours)
  • Number of neonates that have hypocalcemia(during admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year)
  • Number of neonates that have blood glucose level less than 40 mg/dL(during birth admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year)
  • Number of neonates that had respiratory distress(first 24 hours of life)
  • Number of days neonates are admitted to NICU(from birth up to 6 months from birth)
  • Number of neonates that are small for gestational age(at birth)
  • Number of neonates that have neonatal hyperbilirubinemia requiring phototherapy(during admission defined as birth time of neonate until neonate is discharged from hospital, up to 1 year)
  • Number of neonates that have Necrotizing Enterocolitis(from birth up to 6 months from birth)
  • Number of neonates that are large for gestational age(at birth)
  • Number of neonates that have Macrosomia(at time of birth)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ghamar Bitar

Fellow

The University of Texas Health Science Center, Houston

Study Sites (2)

Loading locations...

Similar Trials